Quest Diagnostics Incorporated Common Stock (DGX) stock analysis
DGX · Quest Diagnostics Incorporated Common Stock
Latest recorded price: USD 262.34
Model-estimated fair value: USD 150.99. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Diagnostics & Research
At $262.34, DGX trades 73.7% above the model's base-case value of $150.99. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $116.15 in the conservative case and $190.45 in the optimistic case, with a valuation confidence score of 75/100. About 81% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 3.7%, free cash flow margin 12.3%, ROIC 10.3%. The model flags 1 risk signal for this company.
Similar companies in Healthcare
- Danaher Corporation Common Stock (DHR)
- Guardant Health, Inc. (GH)
- IDEXX Laboratories, Inc. - Common Stock (IDXX)
- Illumina, Inc. - Common Stock (ILMN)
- IQVIA Holdings, Inc. Common Stock (IQV)
- Labcorp Holdings Inc. Common Stock (LH)
- Medpace Holdings, Inc. - Common Stock (MEDP)
- Mettler-Toledo International Inc. (MTD)